BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive it has paid off $650,000 in debt, the bulk of which was scheduled to mature in August 2021. Calvert says aside from the debt carried by its partially owned subsidiary Clyra Medical, only SBA loans and fixed-price convertible debt remain on BioLargo's balance sheet, which falls in line with the company's goals to aggressively reduce or eliminate its convertible debt instruments in favor of equity-based transactions.
BioLargo retires $650,000 in debt, following its plan to focus more on equity-based transactions
